Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02381990Recruiting

MRI/Ultrasound Fusion Guided Prostate Cryotherapy

Role: lead

NCT05241236Recruiting

MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

Role: lead

NCT05698576Not ApplicableRecruiting

TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer

Role: lead

NCT05218811Not ApplicableRecruiting

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Role: lead

NCT04760483Phase 1Active Not Recruiting

Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA

Role: lead

All 5 trials loaded